Cargando…

Harnessing Protein-Ligand Interaction Fingerprints to Predict New Scaffolds of RIPK1 Inhibitors

Necroptosis has emerged as an exciting target in oncological, inflammatory, neurodegenerative, and autoimmune diseases, in addition to acute ischemic injuries. It is known to play a role in innate immune response, as well as in antiviral cellular response. Here we devised a concerted in silico and e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aniceto, Natália, Marques, Vanda, Amaral, Joana D., Serra, Patrícia A., Moreira, Rui, Rodrigues, Cecília M. P., Guedes, Rita C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330098/ https://www.ncbi.nlm.nih.gov/pubmed/35897894 http://dx.doi.org/10.3390/molecules27154718

Ejemplares similares

Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibition
por: Brito, Hugo, et al.
Publicado: (2020)

Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision Therapy
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2022)

The scaffold-dependent function of RIPK1 in experimental non-alcoholic steatohepatitis
por: Pistorio, Valeria, et al.
Publicado: (2022)

Harnessing the Microbiome to Reduce Pancreatic Cancer Burden
por: Bastos, Ana Raquel, et al.
Publicado: (2023)

Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling
por: Hrdinka, Matous, et al.
Publicado: (2018)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

Exploring the Chemical Space of Urease Inhibitors to Extract Meaningful Trends and Drivers of Activity
por: Aniceto, Natália, et al.
Publicado: (2022)

The scaffold-dependent function of RIPK1 in dendritic cells promotes injury-induced colitis
por: Moriwaki, Kenta, et al.
Publicado: (2021)

Ripk1 and haematopoiesis: a case for LUBAC and Ripk3
por: Annibaldi, Alessandro, et al.
Publicado: (2018)

Chemical Patterns of Proteasome Inhibitors: Lessons Learned from Two Decades of Drug Design
por: Guedes, Romina A., et al.
Publicado: (2019)

RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
por: Ke, Dan, et al.
Publicado: (2023)

Advances in RIPK1 kinase inhibitors
por: Chen, Lu, et al.
Publicado: (2022)

RIPK1 blocks T cell senescence mediated by RIPK3 and caspase-8
por: Imanishi, Takayuki, et al.
Publicado: (2023)

Erratum: Advances in RIPK1 kinase inhibitors
Publicado: (2023)

TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1
por: Moujalled, D M, et al.
Publicado: (2013)

HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2
por: Wagner, Roland N., et al.
Publicado: (2015)

Identification of MYC as an antinecroptotic protein that stifles RIPK1–RIPK3 complex formation
por: Seong, Daehyeon, et al.
Publicado: (2020)

Harnessing cyclotides to design and develop novel peptide GPCR ligands
por: Muratspahić, Edin, et al.
Publicado: (2020)

TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer
por: Lin, Penghang, et al.
Publicado: (2023)

Necroptosis: Fifty shades of RIPKs
por: Ichim, Gabriel, et al.
Publicado: (2014)

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease
por: Afonso, Marta B., et al.
Publicado: (2023)

RIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
por: Barbosa, Laiana A., et al.
Publicado: (2018)

TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3
por: Dowling, John P., et al.
Publicado: (2019)

Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death
por: Frank, Daniel, et al.
Publicado: (2022)

Using Machine Learning and Molecular Docking to Leverage Urease Inhibition Data for Virtual Screening
por: Aniceto, Natália, et al.
Publicado: (2023)

Harnessing the Versatility of Bacterial Collagen to Improve the Chondrogenic Potential of Porous Collagen Scaffolds
por: Parmar, Paresh A., et al.
Publicado: (2016)

RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system
por: Li, Dianrong, et al.
Publicado: (2017)

Harnessing asymmetric N-heterocyclic carbene ligands to optimise SABRE hyperpolarisation
por: Wong, Chin Min, et al.
Publicado: (2018)

PyPLIF: Python-based Protein-Ligand Interaction Fingerprinting
por: Radifar, Muhammad, et al.
Publicado: (2013)

Thermodynamic fingerprints of ligand binding to human telomeric G-quadruplexes
por: Bončina, Matjaž, et al.
Publicado: (2015)

Exploring EZH2-Proteasome Dual-Targeting Drug Discovery through a Computational Strategy to Fight Multiple Myeloma
por: Estrada, Filipe G. A., et al.
Publicado: (2021)

Execution of RIPK3-regulated necrosis
por: Cai, Zhenyu, et al.
Publicado: (2014)

QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping
por: Škuta, C., et al.
Publicado: (2020)

Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death
por: Moriwaki, K, et al.
Publicado: (2015)

Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
por: Zhang, Xixi, et al.
Publicado: (2019)

Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1–RIPK3-Dependent Pathway in Mice
por: Wu, Penglong, et al.
Publicado: (2021)

Investigation on the expression regulation of RIPK1/RIPK3 in the retinal ganglion cells (RGCs) cultured in high glucose
por: Gao, Sheng, et al.
Publicado: (2021)

RIPK1 and RIPK3 regulate TNFα-induced β-cell death in concert with caspase activity
por: Contreras, Christopher J., et al.
Publicado: (2022)

Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1
por: Peng, Ruoshi, et al.
Publicado: (2022)

Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation
por: Takiishi, Tatiana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_78s90bpkbm5vvcke3bkoacbro7